Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence

Glioblastoma (GB) is the most common primary malignant brain tumor, and despite the availability of chemotherapy and radiotherapy to combat the disease, overall survival remains low with a high incidence of tumor recurrence. Technological advances are continually improving our understanding of the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Hayley P., Greenslade, Mark, Powell, Ben, Spiteri, Inmaculada, Sottoriva, Andrea, Kurian, Kathreena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644939/
https://www.ncbi.nlm.nih.gov/pubmed/26636033
http://dx.doi.org/10.3389/fonc.2015.00251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644939/
https://www.ncbi.nlm.nih.gov/pubmed/26636033
http://dx.doi.org/10.3389/fonc.2015.00251

Ejemplares similares